Key facts
- This page summarizes Reed L. Benson's Form 4 filing for Co-Diagnostics, Inc. (CODX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 26 May 2021, 12:01.
Reed L. Benson - 24 May 2021 Form 4 Insider Report for Co-Diagnostics, Inc. (CODX)
- Reporting relationship
- General Counsel
- Issuer ticker
- CODX
- Reported as of
- 24 May 2021
- Net transaction value
- -$11,170
- SEC form
- 4
- Accepted by SEC
- 26 May 2021, 12:01:54 UTC
- Prior SEC filing
- 21 May 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Reed L. Benson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Reed L. Benson filed Form 4 for Co-Diagnostics, Inc. (CODX) on 26 May 2021.
Change
- Previous filing in this sequence was filed on 21 May 2021.
- Current net transaction value: -$11,170.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CODX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +4,584
- Change %
- Price
- $0.000000
- Shares after
- 4,584
- Date
- 24 May 2021
- Ownership
- Direct
- Footnotes
- F1
CODX
transaction
Common Stock
Tax liability
- Transaction value
- $11,170
- Shares
- -1,414
- Change %
- -31%
- Price
- $7.90*
- Shares after
- 3,170
- Date
- 24 May 2021
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CODX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -4,584
- Change %
- -17%
- Price
- $0.000000
- Shares after
- 22,916
- Date
- 24 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 27,500
- Exercise price
- $0.000000
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Included in 27,500 restricted stock units awarded to the Reporting Person on November 23, 2020, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on May 24, 2021.
Footnote F2
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.